Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDNOS 2
ISRCTN10900733Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of prednisolone in nephrosis (2 arms), sponsored by University of Birmingham. Primary endpoint: First URTI-related relapse of nephrotic syndrome during the 12-month follow-up period. Started Nov 2012; status: completed.
02
Drugs
prednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on ISRCTN10900733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10900733.